Medicine & Life Sciences
Hematopoietic Stem Cell Transplantation
100%
Stem Cell Transplantation
93%
Allogeneic Cells
70%
Transplants
69%
Graft vs Host Disease
62%
Melphalan
58%
fludarabine
56%
Multiple Myeloma
55%
Busulfan
52%
Transplantation
51%
Survival
41%
Cell Transplantation
41%
Fetal Blood
37%
Progression-Free Survival
37%
Unrelated Donors
29%
Tissue Donors
29%
Hematopoietic Stem Cells
28%
Mortality
26%
Cyclophosphamide
26%
Stem Cells
25%
Rituximab
25%
Drug Therapy
25%
Lymphoma
23%
Hodgkin Disease
23%
Non-Hodgkin's Lymphoma
23%
Tacrolimus
21%
Acute Myeloid Leukemia
20%
Lymphoma, Large B-Cell, Diffuse
20%
Recurrence
20%
Clofarabine
20%
Hematologic Neoplasms
19%
Homologous Transplantation
19%
Chimeric Antigen Receptors
17%
Myelodysplastic Syndromes
17%
Autologous Transplantation
17%
Therapeutics
16%
Confidence Intervals
16%
Incidence
15%
Hematopoietic Stem Cell Mobilization
15%
GATA2 Deficiency
14%
T-Lymphocytes
13%
Neoplasms
13%
B-Cell Lymphoma
12%
gemcitabine
12%
Transplant Recipients
11%
B-Cell Chronic Lymphocytic Leukemia
11%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10%
Vorinostat
10%
FM 100
10%
Haploidentical Transplantation
10%